119 results on '"Bruton, Rachel"'
Search Results
2. Nasal mucosal IgA levels against SARS-CoV-2 and seasonal coronaviruses are low in children but boosted by reinfection
3. Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes
4. Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study
5. Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection
6. Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection
7. Extended interval BNT162b2 vaccination enhances peak antibody generation
8. Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia
9. Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study
10. Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5–6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis
11. Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia
12. Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people
13. Robust generation of neutralising antibodies against omicron variants following bivalent mRNA booster vaccine in elderly people aged >80 years
14. Robust generation of neutralising antibodies against Omicron variants following bivalent mRNA booster vaccine in elderly people aged >80 years
15. An immunological and biochemical investigation of some central metabotropic glutamate receptors (mGluRs)
16. The Significance of the CtBP — AdE1A Interaction during Viral Infection and Transformation
17. Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people
18. Immunological imprinting of humoral immunity to SARS-CoV-2 in children
19. COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia
20. mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273
21. Strong peak immunogenicity but rapid antibody waning following third vaccine dose in elderly residents of care homes
22. Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI)
23. Additional file 2 of Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia
24. Additional file 3 of Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia
25. Additional file 1 of Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia
26. Additional file 4 of Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia
27. SARS-CoV-2 anti-spike antibody levels following second dose of ChAdOx1 nCov-19 or BNT162b2 in residents of long-term care facilities in England (VIVALDI)
28. The number of cytomegalovirus-specific CD4+ T cells is markedly expanded in patients with B-cell chronic lymphocytic leukemia and determines the total CD4+ T-cell repertoire
29. Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection
30. mRNA COVID-19 vaccines induce enhanced antibody and cellular responses compared to ChAdOx1 or natural infection in children
31. mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant
32. Author response: mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant
33. Robust SARS-CoV-2-specific and heterologous immune responses after natural infection in elderly residents of Long-Term Care Facilities
34. Differential Immunogenicity of BNT162b2 or ChAdOx1 Vaccines After Extended-Interval Homologous Dual Vaccination in Older People
35. Additional file 1 of Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people
36. Children develop robust and sustained cross-reactive spike-specific immune responses following SARS-CoV-2 infection
37. Booster Vaccination Strongly Enhances SARS-CoV-2-Specific Antibody and Cellular Responses in Elderly Residents of Care Homes
38. Reduced Antibody and Cellular Immune Responses Following Dual COVID-19 Vaccination Within Infection-Naïve Residents of Long-Term Care Facilities
39. Profile of Humoral and Cellular Immune Responses to Single BNT162b2 or ChAdOx1 Vaccine in Residents and Staff Within Residential Care Homes (VIVALDI Study)
40. Antibody Responses After First and Second COVID-19 Vaccination in Patients With Chronic Lymphocytic Leukaemia
41. Impaired Neutralisation of SARS-CoV-2 Delta Variant in Vaccinated Patients With B Cell Chronic Lymphocytic Leukaemia
42. Analysis of the immunological response to coronavirus infection
43. Cadherin and catenin biology represent a global mechanism for epithelial cancer progression
44. Group I mGlu receptor modulation of dopamine release in the rat striatum in vivo
45. Intercalation predicts improved academic performance across the medical undergraduate curriculum
46. The Significance of the CtBP — AdE1A Interaction during Viral Infection and Transformation
47. [3H]-GABA Binding to GABAA and GABAB Sites on Rat Brain Crude Synaptic Membranes
48. Doxazosin induces apoptosis in PTEN–positive androgen-independent PC cells via inhibition of A kt activation
49. Identification of a Second CtBP Binding Site in Adenovirus Type 5 E1A Conserved Region 3
50. A Role for E1B-AP5 in ATR Signaling Pathways during Adenovirus Infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.